Elixia, Phase 1 Clinical Site — Tampa, Florida

Elixia, Phase 1 Clinical Site is a clinical research site located in Tampa, Florida, United States 33618.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Elixia, Phase 1 Clinical Site has participated in 1 clinical trials.

Therapeutic areas: Pain.

Sponsors: Vertex Pharmaceuticals Incorporated.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Elixia, Phase 1 Clinical Site?

Elixia, Phase 1 Clinical Site has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Elixia, Phase 1 Clinical Site conducted?

Elixia, Phase 1 Clinical Site has 1 clinical trials on record. Their work covers Pain.

Is Elixia, Phase 1 Clinical Site accredited by Crixeo Health?

Elixia, Phase 1 Clinical Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Elixia, Phase 1 Clinical Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.